Total Payments
$870.06
2024 Payments
$37.62
Companies
10
Transactions
26
Medicare Patients
2,169
Medicare Billing
$356,815

Payment Breakdown by Category

Food & Beverage$870.06 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $870.06 26 100.0%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $183.48 4 $0 (2023)
AstraZeneca Pharmaceuticals LP $166.45 3 $0 (2023)
Amgen Inc. $119.30 1 $0 (2019)
Novartis Pharmaceuticals Corporation $115.65 5 $0 (2023)
Janssen Pharmaceuticals, Inc $102.85 5 $0 (2024)
Kestra Medical Technology Services, Inc. $75.31 3 $0 (2023)
Boston Scientific Corporation $37.98 2 $0 (2022)
ABBVIE INC. $27.86 1 $0 (2022)
SANOFI-AVENTIS U.S. LLC $24.69 1 $0 (2022)
Cumberland Pharmaceuticals, Inc. $16.49 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $37.62 2 Janssen Pharmaceuticals, Inc ($37.62)
2023 $198.85 9 Janssen Pharmaceuticals, Inc ($48.59)
2022 $353.71 11 E.R. Squibb & Sons, L.L.C. ($138.49)
2021 $35.59 2 BOSTON SCIENTIFIC CORPORATION ($18.95)
2020 $124.99 1 AstraZeneca Pharmaceuticals LP ($124.99)
2019 $119.30 1 Amgen Inc. ($119.30)

All Payment Transactions

26 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/22/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.24 General
Category: Cardiovascular & Metabolism
04/12/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.38 General
Category: Cardiovascular & Metabolism
08/12/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $26.66 General
Category: Cardiovascular & Metabolism
07/13/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $20.08 General
Category: Cardiovascular
06/28/2023 Cumberland Pharmaceuticals, Inc. CALDOLOR (Drug) Food and Beverage In-kind items and services $16.49 General
Category: ANESTHESIOLOGY PAIN MANAGEMENT
05/04/2023 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $25.39 General
Category: Cardiology
04/06/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $21.93 General
Category: Cardiovascular & Metabolism
03/23/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $24.44 General
Category: Cardiology/Vascular Diseases
02/09/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $17.42 General
Category: Cardiovascular and Metabolism
01/26/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $24.91 General
Category: Cardiovascular
01/04/2023 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $21.53 General
Category: Cardiology
12/01/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $25.00 General
Category: CARDIOVASCULAR
11/28/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $21.23 General
Category: CARDIOVASCULAR
09/22/2022 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $19.03 General
Category: WATCHMAN_IC
07/15/2022 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $28.39 General
Category: Cardiology
06/30/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $15.73 General
Category: Cardiovascular
06/23/2022 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $122.76 General
Category: Cardiovascular
06/16/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $21.73 General
Category: CARDIOVASCULAR
06/15/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $24.04 General
Category: Cardiovascular and Metabolism
06/01/2022 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $24.69 General
Category: Cardiology/Vascular Diseases
05/09/2022 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $27.86 General
Category: ANTI-INFECTIVE
03/10/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $23.25 General
Category: CARDIOVASCULAR
09/24/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.64 General
Category: Cardiovascular & Metabolism
05/18/2021 BOSTON SCIENTIFIC CORPORATION GENERAL - VASCULAR INTERVENTION (Device) Food and Beverage In-kind items and services $18.95 General
Category: VASCULAR
02/12/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 962 2,079 $627,643 $165,381
2022 7 836 1,819 $504,953 $134,622
2021 6 371 692 $199,132 $56,812
Total Patients
2,169
Total Services
4,590
Medicare Billing
$356,815
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 497 1,599 $431,730 $113,724 26.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 299 310 $121,830 $32,393 26.6%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 121 124 $55,428 $14,365 25.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 15 15 $8,865 $2,329 26.3%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 18 19 $7,714 $2,064 26.8%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 12 12 $2,076 $507.10 24.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 389 1,332 $326,340 $86,721 26.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 247 258 $92,622 $24,798 26.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 94 95 $44,555 $11,883 26.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 42 46 $16,146 $4,369 27.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 21 21 $14,301 $3,870 27.1%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 31 49 $6,615 $1,797 27.2%
99225 Follow-up observation care per day, typically 25 minutes Facility 2022 12 18 $4,374 $1,184 27.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 153 412 $97,644 $27,768 28.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 112 115 $40,135 $11,512 28.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 48 101 $34,037 $9,792 28.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 29 29 $13,137 $3,739 28.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 18 18 $11,952 $3,392 28.4%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 11 17 $2,227 $609.62 27.4%

About Dr. Khaled Jamoor, MD

Dr. Khaled Jamoor, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1841795382.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khaled Jamoor, MD has received a total of $870.06 in payments from pharmaceutical and medical device companies, with $37.62 received in 2024. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($870.06).

As a Medicare-enrolled provider, Jamoor has provided services to 2,169 Medicare beneficiaries, totaling 4,590 services with total Medicare billing of $356,815. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.

Practice Information

Products in Payments

  • CAMZYOS (Drug) $138.49
  • LOKELMA (Drug) $124.99
  • Prolia (Biological) $119.30
  • ENTRESTO (Drug) $115.65
  • XARELTO (Drug) $102.85
  • Assure WCD (Device) $75.31
  • ELIQUIS (Drug) $44.99
  • DALVANCE (Drug) $27.86
  • MULTAQ (Drug) $24.69
  • BRILINTA (Drug) $24.04
  • WATCHMAN Access System (Device) $19.03
  • GENERAL - VASCULAR INTERVENTION (Device) $18.95
  • FARXIGA (Drug) $17.42
  • CALDOLOR (Drug) $16.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Providence